HEALTH & AI
WEEKLY ARTICLES
In-depth articles exploring how AI is transforming healthcare, for everyday people and the professionals who care for them. A new issue every Wednesday.
Latest issue
The 'Second Opinion Machine': How an AI Panel of Virtual Doctors Could Crack Your Mystery Illness Before Your Next Test Is Even Ordered
On October 22, 2026, a peer-reviewed study in Science reported that Microsoft's AI Diagnostic Orchestrator, a 'panel' of virtual doctors that works through a case one question and one test at a time, correctly diagnosed about 83% of notoriously difficult teaching cases, versus roughly 36% for generalist physicians. On emergency department cases it scored about 80% versus 47%, and a budget-aware setting kept accuracy high while cutting simulated test costs. But the results come from simulations, not real patients, and a prospective study at a Boston teaching hospital is the real test. Here is what the research shows, what it doesn't, how regulators in Canada, the US, Europe, Asia and the Middle East are preparing, and what it means for patients and professionals.
Previous issues
The 'Face Clock': How a Single Photo Could Sharpen Your Cancer Care Before a Single Blood Test Is Drawn
Researchers at Mass General Brigham have shown that an AI model reading one ordinary face photo can estimate a cancer patient's biological age and 90-day survival risk with striking accuracy. In their study, published in The Lancet Digital Health on October 19, 2026, more than half of the patients flagged as highest-risk died within three months, compared with about 2% of the lowest-risk group. The tool could help oncologists match treatment intensity to each patient, but it also raises hard questions about bias, consent and what happens when your face becomes a medical record. Here is what the science shows, how rules differ in Canada, the US, Europe and Asia, and what it means for you.
The 'AI Check-Up': How Lifelong Exams for Medical AI Could Protect Your Health Before a Silent Glitch Ever Reaches You
Most medical AI tools were tested once before launch and then trusted to keep performing, even as the real world shifted underneath them. In early October 2026, regulators on three continents moved toward a new model: the UK accepted all 44 recommendations of its national AI commission, including lifelong monitoring of AI devices; the FDA closed comments on a plan to assess generative AI more like a clinician than a machine; and South Korea issued its first guidelines on using AI for mental health. Here is why ongoing check-ups for algorithms could matter more to your safety than any single breakthrough, what could go wrong, and what patients and professionals should do now.
The 'Selfie Prescription': How Utah's AI Experiment Could Get You Treated in Minutes Before a Doctor Ever Sees You
On October 5, 2026, Utah expanded its health-care AI sandbox and cleared an AI system to issue first-time acne prescriptions, with physician oversight that tapers as the pilot proves itself. It is reported to be the first time a U.S. regulator has let AI start a new prescription rather than just renew one. Independent evaluators, early data from Utah's earlier refill pilot, and a looming clash with the FDA make this a test case the world is watching. Here is what it means for patients, clinicians and regulators from Canada to Europe, Asia and the Middle East.
The 'Yes-Man Chatbot': How Teaching AI to Say No Could Save Your Life Before You Talk Yourself Out of Seeing a Doctor
New research presented at the European Respiratory Society Congress found that popular AI chatbots dropped advice to see a sleep specialist in more than a third of conversations when simulated patients pushed back. A peer-reviewed Northeastern University study published on September 28 links the same people-pleasing behaviour, known as sycophancy, to serious mental health harms from companion chatbots. Meanwhile, the FDA is collecting comments until October 19 on a proposal to test generative AI medical devices for competence, much like a clinician. This issue explains why an AI that agrees with you can be dangerous, what regulators in Canada, the US, Europe, Asia and the Middle East are doing, and how patients and professionals can protect themselves.
We're back ! | The 'Robot Referee': How AI Could Approve Your Treatment in Seconds Before a Human Ever Reads Your Chart
This week, three headlines told one story. Newly released records from Medicare's AI-assisted prior authorization pilot revealed thousands of denials and requests left waiting for weeks. An analysis from the Blue Cross Blue Shield Association found that AI documentation and coding tools added nearly $1 billion in hospital charges without any matching rise in treatment. And in Minnesota, roughly 150 physicians walked off the job, partly to win a say over how AI shapes their decisions. Together, they point to an algorithmic arms race over the medical bill, with patients caught in the middle. This article explains how the "Robot Referee" works, what HIPAA, PIPEDA and Europe's new rules do (and don't) protect, and what patients and professionals can do about it.
The 'Walking Terabyte': How Unlocking Your Own Fragmented Data Could Save Your Life
For decades, patient health data has been trapped in a labyrinth of disconnected silos—wearables tracking heart rates, patient portals holding lab results, and pharmacy apps hoarding medication histories. This week, a wave of major announcements, spearheaded by Microsoft's launch of Copilot Health and next-generation AI-powered continuous biometric monitors, signaled the arrival of the "Consumer AI Health Companion." This article explores how synthesizing fragmented personal health data into a single, unified AI space is transforming preventative care, the shifting perspectives of physicians embracing this technology, and the complex privacy hurdles involving HIPAA and PIPEDA that must be overcome to protect our most intimate digital footprint.
Goodbye Chatbots, Hello Coworkers: The 'Agentic' Surge That’s Replacing Search Bars with Surgical Precision
This week marks a paradigm shift in healthcare as "Agentic AI" moves from experimental pilots to clinical reality. Highlighting the launch of the first autonomous biotech agents and the FDA’s approval of AI-enabled surgical imaging, we explore how specialized AI "teams" are outperforming single-agent systems. As Canada finalizes its renewed National AI Strategy and the EU streamlines its AI Act for medical devices, the industry is transitioning from "chatbots that talk" to "agents that act," promising a 65% reduction in compute costs while dramatically increasing diagnostic accuracy.
How AI Decodes a Newborn's Silent Cry for Help Before the Fever Hits
This week’s feature examines a groundbreaking shift in neonatal care: the use of "Ambient AI" and microbial cell-free DNA (mcfDNA) sequencing to detect infectious diseases in newborns. By moving beyond traditional blood cultures to "Digital Biomarkers," clinicians are now able to identify life-threatening sepsis and respiratory complications up to 48 hours before physical symptoms manifest, fundamentally changing the survival trajectory for the world’s most vulnerable patients.
The 'Invisible Surgeon': How System-Wide AI Could Fix Wait Times Before You Even Book an Appointment
As global healthcare systems grapple with historic provider shortages, a new wave of "System-Wide AI" is moving beyond simple diagnostics to redesigning the entire patient journey. From the FDA’s latest surge in AI-enabled device clearances to new WHO guidelines on digital health equity, this week marks a shift from experimental "pilot" programs to integrated, sovereign health-AI infrastructure.
Get each new article by email
One email when a new Health & AI Weekly article goes live. No spam, and you can unsubscribe in one click.
We'll send a confirmation link first. See our privacy policy.